Are metabolic syndrome and its components a risk factor for gallbladder polyps?

Main Article Content

Emine Duygu Boz
Refik Demirtunç
Mehmet Sözen

Abstract

Background. Gallbladder polyps are usually benign lesions originating from the mucosa and are usually detected incidentally during radiological examinations or after cholecystectomy. Gallbladder polyps are common and may have malignant risk. In this study, it was investigated whether metabolic syndrome (MS) is a risk factor for gallbladder polyps. This study aimed to determine the prevalence of MS and its components in patients with gallbladder polyps. Materials and methods. We conducted a retrospective, cross-sectional study. We investigated the age, gender and past medical history of 90 adults (45 with polyps, 45 without polyps). Body height and weight, body mass index, waist circumference and laboratory data were obtained from the hospital data processing system. National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) and International Diabetes Foundation (IDF) MS diagnostic criterion were used for the diagnosis of MS. Results. 51.1 % (n = 46) of the subjects participating in the study were female and 48.8 % (n = 44) were male. The mean age was 58.79 ± 15.70 years. MS was found in 56.7 % (n = 51) of the cases according to the criteria of NCEP-ATP III and, in 64.4 % (n = 58) of the cases according to the IDF criteria. In patients with a gallbladder polyp, MS was detected in 55.55 % according to the criteria of NCEP-ATP III and in 66.66 % according to the IDF criteria. The rates of MS were not similar in the gallbladder polyp group and control group (p > 0.01). Abdominal obesity was found to be a risk factor for the development of gallbladder polyp (odds ratio: 14.23, 95% CI: 1.751–15.722; p < 0.01). Although it was not statistically significant, low HDL and hypertension were detected approximately 2 times higher in patients with gallbladder polyps than in the control group. Conclusions. While MS is not associated with the development of gallbladder polyp, obesity is seen as a sole risk factor.

Article Details

How to Cite
Duygu Boz, E., R. Demirtunç, and M. Sözen. “Are Metabolic Syndrome and Its Components a Risk Factor for Gallbladder Polyps?”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 17, no. 3, June 2021, pp. 214-8, doi:10.22141/2224-0721.17.3.2021.232650.
Section
Original Researches

References

Bhatt NR, Gillis A, Smoothey CO, Awan FN, Ridgway PF. Evidence based management of polyps of the gall bladder: A systematic review of the risk factors of malignancy. Surgeon. 2016 Oct;14(5):278-86. doi:10.1016/j.surge.2015.12.001.

Heitz L, Kratzer W, Gräter T, Schmidberger J; EMIL study group. Gallbladder polyps - a follow-up study after 11 years. BMC Gastroenterol. 2019 Mar 18;19(1):42. doi:10.1186/s12876-019-0959-3.

McCain RS, Diamond A, Jones C, Coleman HG. Current practices and future prospects for the management of gallbladder polyps: A topical review. World J Gastroenterol. 2018 Jul 14;24(26):2844-2852. doi:10.3748/wjg.v24.i26.2844.

Choi YS, Do JH, Seo SW, et al. Prevalence and Risk Factors of Gallbladder Polypoid Lesions in a Healthy Population. Yonsei Med J. 2016 Nov;57(6):1370-5. doi:10.3349/ymj.2016.57.6.1370.

Lim SH, Kim DH, Park MJ, et al. Is Metabolic Syndrome One of the Risk Factors for Gallbladder Polyps Found by Ultrasonography during Health Screening? Gut Liver. 2007 Dec;1(2):138-44. doi:10.5009/gnl.2007.1.2.138.

Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009 May-Jun;2(5-6):231-7. doi:10.1242/dmm.001180.

Méndez-Sánchez N, Chavez-Tapia NC, Motola-Kuba D, et al. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol. 2005 Mar 21;11(11):1653-7. doi:10.3748/wjg.v11.i11.1653.

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001 May 16;285(19):2486-97. doi:10.1001/jama.285.19.2486.

Alberti KG, Zimmet P, Shaw J. Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006 May;23(5):469-80. doi:10.1111/j.1464-5491.2006.01858.x.

Pickering O, Pucher PH, Toale C, et al. Prevalence and Sonographic Detection of Gallbladder Polyps in a Western European Population. J Surg Res. 2020 Jun;250:226-231. doi:10.1016/j.jss.2020.01.003.

Babu BI, Dennison AR, Garcea G. Management and diagnosis of gallbladder polyps: a systematic review. Langenbecks Arch Surg. 2015 May;400(4):455-62. doi:10.1007/s00423-015-1302-2.

Gurusamy KS, Abu-Amara M, Farouk M, Davidson BR. Cholecystectomy for gallbladder polyp. Cochrane Database Syst Rev. 2009 Jan 21;2009(1):CD007052. doi:10.1002/14651858.CD007052.pub2.

Wiles R, Thoeni RF, Barbu ST, et al. Management and follow-up of gallbladder polyps : Joint guidelines between the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), European Association for Endoscopic Surgery and other Interventional Techniques (EAES), International Society of Digestive Surgery - European Federation (EFISDS) and European Society of Gastrointestinal Endoscopy (ESGE). Eur Radiol. 2017 Sep;27(9):3856-3866. doi:10.1007/s00330-017-4742-y.

Park JK, Yoon YB, Kim YT, et al. Management strategies for gallbladder polyps: is it possible to predict malignant gallbladder polyps? Gut Liver. 2008 Sep;2(2):88-94. doi:10.5009/gnl.2008.2.2.88.

Ahn DW, Jeong JB, Kang J, et al. Fatty liver is an independent risk factor for gallbladder polyps. World J Gastroenterol. 2020 Nov 28;26(44):6979-6992. doi:10.3748/wjg.v26.i44.6979.

Dairi S, Demeusy A, Sill AM, Patel ST, Kowdley GC, Cunningham SC. Implications of gallbladder cholesterolosis and cholesterol polyps? J Surg Res. 2016 Feb;200(2):467-72. doi:10.1016/j.jss.2015.08.037.

Lee YJ, Park KS, Cho KB, et al. Shifting prevalence of gallbladder polyps in Korea. J Korean Med Sci. 2014 Sep;29(9):1247-52. doi:10.3346/jkms.2014.29.9.1247.

Oh JS, Lee HM, Lin TC, et al. Relationship between Gallbladder Polyps and Metabolic Syndrome Components in Korean Male Adults. Korean J Fam Pract. 2018;8(1):21-24. doi:10.21215/kjfp.2018.8.1.21.

Lee JK, Hahn SJ, Kang HW, et al. Visceral Obesity Is Associated with Gallbladder Polyps. Gut Liver. 2016 Jan;10(1):133-9. doi:10.5009/gnl14506.

Yamin Z, Xuesong B, Guibin Y, Liwei L, Fei L. Risk factors of gallbladder polyps formation in East Asian population: A meta-analysis and systematic review. Asian J Surg. 2020 Jan;43(1):52-59. doi:10.1016/j.asjsur.2019.03.015.

Li Y, Tejirian T, Collins JC. Gallbladder Polyps: Real or Imagined? Am Surg. 2018 Oct 1;84(10):1670-1674.

Lim SH, Kim D, Kang JH, et al. Hepatic fat, not visceral fat, is associated with gallbladder polyps: a study of 2643 healthy subjects. J Gastroenterol Hepatol. 2015 Apr;30(4):767-74. doi:10.1111/jgh.12841.

Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver. 2012 Apr;6(2):172-87. doi:10.5009/gnl.2012.6.2.172.

Shabanzadeh DM. Incidence of gallstone disease and complications. Curr Opin Gastroenterol. 2018 Mar;34(2):81-89. doi:10.1097/MOG.0000000000000418.